These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11302022)

  • 21. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 22. WHO official warns of crisis in supply of low cost AIDS drugs.
    Zarocostas J
    BMJ; 2005 Nov; 331(7525):1104. PubMed ID: 16282404
    [No Abstract]   [Full Text] [Related]  

  • 23. Affordable drugs for developing countries.
    Chong CY
    Hong Kong Med J; 2003 Apr; 9(2):148-9. PubMed ID: 12668831
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 25. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV treatment strategies must shift to DM focus.
    Healthc Demand Dis Manag; 1998 Oct; 4(10):145-51. PubMed ID: 10338755
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinton brokers deal to lower price of antiretrovirals.
    Abimbola S
    BMJ; 2007 May; 334(7602):1026. PubMed ID: 17510129
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment. HIV drug spending up; Merck offers discounts.
    AIDS Policy Law; 2010 Jun; 25(7):1. PubMed ID: 20607912
    [No Abstract]   [Full Text] [Related]  

  • 29. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 30. The looming crisis in drug pricing.
    Delaney M
    GMHC Treat Issues; 2002 Apr; 16(4):12. PubMed ID: 12141258
    [No Abstract]   [Full Text] [Related]  

  • 31. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 32. Drugs should be affordable to India's poor to fight HIV/AIDS.
    Agoramoorthy G; Hsu MJ
    AIDS; 2006 Oct; 20(15):1988-9. PubMed ID: 16988526
    [No Abstract]   [Full Text] [Related]  

  • 33. Economic impact of HIV.
    Veenstra N; Whiteside A
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):197-210. PubMed ID: 15778110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3 by 5 initiative: treating 3 million by 2005.
    East Mediterr Health J; 2002 Nov; 8(6):835-7. PubMed ID: 15568463
    [No Abstract]   [Full Text] [Related]  

  • 35. Rwanda to receive cheaper anti-HIV drugs for chronic treatment and free viramune to prevent viral transmission from mother to child.
    SADJ; 2001 Apr; 56(4):210. PubMed ID: 11436238
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV/AIDS. The high cost of stolen funds.
    Cohen J
    Science; 2008 Jul; 321(5888):523. PubMed ID: 18653880
    [No Abstract]   [Full Text] [Related]  

  • 37. Big five to cut cost of AIDS drugs.
    S Afr Med J; 2000 Jun; 90(6):582-3. PubMed ID: 10918884
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 39. Africa finds drug giants guilty of excessive pricing.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397
    [No Abstract]   [Full Text] [Related]  

  • 40. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.